| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NGVT | Common Stock | Options Exercise | $63,835 | +2,288 | +27% | $27.90 | 10,811 | 02 Mar 2023 | Direct | |
| transaction | NGVT | Common Stock | Sale | $186,930 | -2,288 | -21% | $81.70 | 8,523 | 02 Mar 2023 | Direct | F1 |
| transaction | NGVT | Common Stock | Options Exercise | $64,104 | +1,207 | +14% | $53.11 | 9,730 | 02 Mar 2023 | Direct | |
| transaction | NGVT | Common Stock | Sale | $98,527 | -1,207 | -12% | $81.63 | 8,523 | 02 Mar 2023 | Direct | F2 |
| transaction | NGVT | Common Stock | Options Exercise | $106,430 | +2,363 | +28% | $45.04 | 10,886 | 02 Mar 2023 | Direct | |
| transaction | NGVT | Common Stock | Sale | $192,868 | -2,363 | -22% | $81.62 | 8,523 | 02 Mar 2023 | Direct | F3 |
| transaction | NGVT | Common Stock | Sale | $244,590 | -2,989 | -35% | $81.83 | 5,534 | 02 Mar 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NGVT | Employee Stock Option (right to buy) | Options Exercise | $0 | -2,288 | -100% | $0.000000* | 0 | 02 Mar 2023 | Common Stock | 2,288 | $27.90 | Direct | F4 |
| transaction | NGVT | Employee Stock Option (right to buy) | Options Exercise | $0 | -1,207 | -100% | $0.000000* | 0 | 02 Mar 2023 | Common Stock | 1,207 | $53.11 | Direct | F5 |
| transaction | NGVT | Employee Stock Option (right to buy) | Options Exercise | $0 | -2,363 | -100% | $0.000000* | 0 | 02 Mar 2023 | Common Stock | 2,363 | $45.04 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.64 to $81.73, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.65, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The option, representing a right to purchase a total of 2,288 shares, became fully vested and exercisable on February 27, 2019. |
| F5 | The option, representing a right to purchase a total of 1,207 shares, became fully vested and exercisable on February 27, 2020. |
| F6 | The option, representing a right to purchase a total of 2,363 shares, became fully vested and exercisable on February 28, 2023. |